Surrey Heartlands

Joint Formulary & PAD

Enoxaparin - Pre-operative / bridging therapy

You are here : Home > Formulary Search > Enoxaparin - Pre-operative / bridging therapy

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Subcutaneous injection (sc)
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :
Important
Prescribe by brand. RSCH / SASH / ASPH = Inhixa brand

Documentation

Guidelines (Local)
Inhixa communication to GP practices in East Surrey - Feb 2021
Guidelines (Local)
NWS Enoxaparin Brand switch primary care comms Nov 2024
Letter to GP
LMWH Pre-op - clarification GP letter - May 2010

PAD Profile

ChemicalSubstance :
Enoxaparin
Indication :
Pre-operative / bridging therapy
Group Name :
Keywords :
Low Molecular Weight Heparins, LMWH
Brand Names Include :
Clexane, Inhixa, enoxaparin BECAT, Arovi
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
3

Other Indications

Below are listed other indications that Enoxaparin is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Pre-operative / bridging therapy.

Committee Recommendations (4)

06 Nov 24 - NW Surrey Medicines Optimisation Group

North West Surrey / ASPH local recommendation:

Ashford & St Peter's Hospitals NHS Foundation Trust are changing the brand of enoxaparin from Clexane to Inhixa (equivalent biosimilar product).

Enoxaparin is a biological medicine and must be prescribed by brand in line with MHRA guidance.

There are limited indications for which enoxaparin should be prescribed in primary care but, where indicated, North West Surrey in conjunction with ASPH are recommending that practices change to using the Inhixa® brand for all new initiations to support patient safety.

See the "NWS Enoxaparin brand switch" document for details

23 Feb 21 - East Surrey MOG

East Surrey / SASH local recommendation:

Inhixa is the preferred brand of enoxaparin at Surrey and Sussex Healthcare NHST trust. Enoxaparin is a biological medicine and must be prescribed by brand in line with MHRA guidance.

See Inhixa communication document for GPs below

22 Jan 18 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Enoxaparin is a biological medicine and must be prescribed by brand in line with MHRA guidance.

Note; differences in the mechanisms for operation in needle guard between presentations of enoxaparin.
28 Apr 10 - Not Set
The committee were informed that pre-operative LMWH is included within the PbR tariff and should therefore be prescribed/provided by the acute trusts. It should be noted that private patients should not receive care that is different to that of NHS patients and on that principle, the pre-operative LMWH should form part of that patients' private care